135 related articles for article (PubMed ID: 35655714)
1. Balance Analysis of Peripheral Neuropathy in Type 2 Diabetes Mellitus Based on Logistic Regression Equation.
Zhang L; Du Q; Yao M; Wang M; Ge B
Scanning; 2022; 2022():2113758. PubMed ID: 35655714
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy.
Zhao XW; Yue WX; Zhang SW; Chen Q
BMC Endocr Disord; 2022 Apr; 22(1):106. PubMed ID: 35443645
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the related risk factors of diabetic peripheral neuropathy].
Nie C; Bao HP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):467-9. PubMed ID: 23627032
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Factors Related to Type 2 Diabetic Peripheral Neuropathy Based on Flash Glucose Monitoring System.
Ma Q
Med Sci Monit; 2023 Jun; 29():e939157. PubMed ID: 37287214
[TBL] [Abstract][Full Text] [Related]
5. TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Zhen Q; Yao N; Chen X; Zhang X; Wang Z; Ge Q
Endocr Pract; 2019 Mar; 25(3):270-278. PubMed ID: 30913011
[TBL] [Abstract][Full Text] [Related]
6. Effect of resistance exercise on peripheral neuropathy in Type 2 diabetes mellitus.
Yang X; Liu L; Yang L; Li W; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1185-1192. PubMed ID: 33268579
[TBL] [Abstract][Full Text] [Related]
7. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer® in patients with type 1 diabetes mellitus.
Lv SL; Fang C; Hu J; Huang Y; Yang B; Zou R; Wang FY; Zhao HQ
Diabetes Res Clin Pract; 2015 Jul; 109(1):130-4. PubMed ID: 25981398
[TBL] [Abstract][Full Text] [Related]
9. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of apelin in the treatment of type 2 diabetic peripheral neuropathy.
Xu H; Wang Q; Wang Q; Che XQ; Liu X; Zhao S; Wang S
Medicine (Baltimore); 2021 Apr; 100(17):e25710. PubMed ID: 33907154
[TBL] [Abstract][Full Text] [Related]
11. Associations of Serum S100B and S100P With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study.
Afarideh M; Zaker Esteghamati V; Ganji M; Heidari B; Esteghamati S; Lavasani S; Ahmadi M; Tafakhori A; Nakhjavani M; Esteghamati A
Can J Diabetes; 2019 Jul; 43(5):336-344.e2. PubMed ID: 30872108
[TBL] [Abstract][Full Text] [Related]
12. Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients.
Hosny SS; Nasr MS; Ibrahim RH; YousryHelal Z
Diabetes Metab Syndr; 2019; 13(1):626-629. PubMed ID: 30641779
[TBL] [Abstract][Full Text] [Related]
13. Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients.
Wu F; Jing Y; Tang X; Li D; Gong L; Zhao H; He L; Li Q; Li R
Acta Diabetol; 2017 Oct; 54(10):925-931. PubMed ID: 28730568
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Significance of Serum Levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Peripheral Neuropathy.
Sun Q; Tang DD; Yin EG; Wei LL; Chen P; Deng SP; Tu LL
Med Sci Monit; 2018 Aug; 24():5943-5950. PubMed ID: 30145601
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of fibrinogen in the occurrence of mild cognitive impairment events in patients with diabetic peripheral neuropathy.
Zhuang Y; Huang H; Fu Z; Zhang J; Cai Q
BMC Endocr Disord; 2022 Nov; 22(1):267. PubMed ID: 36324107
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
[TBL] [Abstract][Full Text] [Related]
17. Association between serum asprosin and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in the community.
Xu LX; Yin JH; Liang D; Li P; Xu MG; Shi GL; Wang Y; Yang J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7569-7575. PubMed ID: 37667933
[TBL] [Abstract][Full Text] [Related]
18. Alpha adrenoceptor agonist-induced microcirculatory oscillations are reduced in diabetic neuropathy.
Schmiedel O; Nurmikko TJ; Schroeter ML; Whitaker R; Harvey JN
Microvasc Res; 2008 Aug; 76(2):124-31. PubMed ID: 18602650
[TBL] [Abstract][Full Text] [Related]
19. Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes.
Yang X; Xu W; Zhu Y; Deng H; Tan Y; Zeng L; Weng J
Neurosci Bull; 2019 Feb; 35(1):25-33. PubMed ID: 30430334
[TBL] [Abstract][Full Text] [Related]
20. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
